Kun Yun Lee, Wan Azman Wan Ahmad, Ee Vien Low, Siow Yen Liau, Lawrence Anchah, Syuhada Hamzah, Houng-Bang Liew, Rosli B Mohd Ali, Omar Ismail, Tiong Kiam Ong, Mas Ayu Said, Maznah Dahlui
INTRODUCTION: The increasing disease burden of coronary artery disease (CAD) calls for sustainable cardiac service. Teaching hospitals and general hospitals in Malaysia are main providers of percutaneous coronary intervention (PCI), a common treatment for CAD. Few studies have analyzed the contemporary data on local cardiac facilities. Service expansion and budget allocation require cost evidence from various providers. We aim to compare the patient characteristics, procedural outcomes, and cost profile between a teaching hospital (TH) and a general hospital (GH).
METHODS: This cross-sectional study was conducted from the healthcare providers' perspective from January 1st to June 30th 2014. TH is a university teaching hospital in the capital city, while GH is a state-level general hospital. Both are government-funded cardiac referral centers. Clinical data was extracted from a national cardiac registry. Cost data was collected using mixed method of top-down and bottom-up approaches. Total hospitalization cost per PCI patient was summed up from the costs of ward admission and cardiac catheterization laboratory utilization. Clinical characteristics were compared with chi-square and independent t-test, while hospitalization length and cost were analyzed using Mann-Whitney test.
RESULTS: The mean hospitalization cost was RM 12,117 (USD 3,366) at GH and RM 16,289 (USD 4,525) at TH. The higher cost at TH can be attributed to worse patients' comorbidities and cardiac status. In contrast, GH recorded a lower mean length of stay as more patients had same-day discharge, resulting in 29% reduction in mean cost of admission compared to TH. For both hospitals, PCI consumables accounted for the biggest proportion of total cost.
CONCLUSIONS: The high PCI consumables cost highlighted the importance of cost-effective purchasing mechanism. Findings on the heterogeneity of the patients, treatment practice and hospitalization cost between TH and GH are vital for formulation of cost-saving strategies to ensure sustainable and equitable cardiac service in Malaysia.
Health Econ. 2008 Jan;17(1 Suppl):S33-45
[PMID:
18186036]
Heart. 2007 Feb;93(2):195-9
[PMID:
16849373]
ISRN Surg. 2011;2011:714935
[PMID:
22084771]
Lancet. 2003 Jan 4;361(9351):13-20
[PMID:
12517460]
Int J Cardiol. 2013 Apr 30;165(1):161-4
[PMID:
21920614]
Glob Health Sci Pract. 2014 Jun 24;2(3):295-306
[PMID:
25276589]
Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):560-6
[PMID:
24939939]
Med J Malaysia. 2008 Sep;63 Suppl C:41-4
[PMID:
19230246]
JAMA. 1998 Sep 16;280(11):1015-9
[PMID:
9749488]
JACC Cardiovasc Interv. 2013 Feb;6(2):99-112
[PMID:
23352820]
Am J Med. 2002 Mar;112(4):255-61
[PMID:
11893363]
Glob Health Action. 2014 Mar 28;7:23573
[PMID:
24685170]
JAMA Cardiol. 2016 May 1;1(2):216-23
[PMID:
27437896]
Neth Heart J. 2013 May;21(5):230-5
[PMID:
23456884]
Health Care Manag Sci. 2004 Feb;7(1):7-16
[PMID:
14977089]
JAMA. 2011 Oct 5;306(13):1461-7
[PMID:
21972308]
J Cardiol. 2004 Sep;44(3):85-92
[PMID:
15500158]
Health Econ. 2007 Apr;16(4):347-59
[PMID:
17031780]
Curr Med Res Opin. 2005 Dec;21(12):1977-84
[PMID:
16368049]
JACC Cardiovasc Interv. 2010 Oct;3(10):1011-9
[PMID:
20965458]
N Engl J Med. 2006 Sep 14;355(11):1169-70
[PMID:
16971724]
J Am Coll Cardiol. 2013 Jul 23;62(4):275-85
[PMID:
23623905]
J Invasive Cardiol. 2007 Nov;19(11):469-75
[PMID:
17986722]
Curr Cardiol Rep. 2014 Apr;16(4):470
[PMID:
24585111]
J Am Coll Cardiol. 2002 Apr 3;39(7):1104-12
[PMID:
11923032]
BMJ Open. 2017 May 28;7(5):e014307
[PMID:
28552843]
Circulation. 2014 Oct 14;130(16):1392-406
[PMID:
25189214]
JAMA. 1990 Sep 19;264(11):1426-31
[PMID:
2391739]
Eur J Prev Cardiol. 2013 Apr;20(2):368-75
[PMID:
22345688]
Cardiol J. 2011;18(4):378-84
[PMID:
21769818]
Cardiovasc Drugs Ther. 2007 Oct;21(5):389-98
[PMID:
17805954]
Cardiovasc Diabetol. 2009 Sep 26;8:53
[PMID:
19781099]